Trial NCT05514912

View at ClinicalTrials.gov 
Org. Study IDs: STUDY00004206
Secondary IDs: NCI-2022-05975 P30CA138292 STUDY00004206 WINSHIP5569-22

Last trial update was posted on 2023-12-26

MeSH Interventions

Albumin-Bound Paclitaxel Cisplatin Gemcitabine Infigratinib Paclitaxel

MeSH Conditions

Cholangiocarcinoma

Other Conditions

Resectable Intrahepatic Cholangiocarcinoma Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 Stage I Intrahepatic Cholangiocarcinoma AJCC v8 Stage II Intrahepatic Cholangiocarcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8

Stopping Reasons

PI has decided to terminate this study due to study supporter pulling support on this study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID